Empirical Therapy for Symptomatic Gastroesophageal Reflux Disease in Primary Care: Determinants of Efficacy

Publisher： Karger

E-ISSN： 1421-9867|76|3-4|207-214

ISSN： 0012-2823

Source： Digestion, Vol.76, Iss.3-4, 2007-12, pp. : 207-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease

By Kahrilas Peter   Miner Philip   Johanson John   Mao Lian   Jokubaitis Leonard   Sloan Sheldon  

Digestive Diseases and Sciences, Vol. 50, Iss. 11, 2005-11 ,pp. : 2009-2018

Springer Publishing Company

Access to resources Recommend Favorite

Gastroesophageal reflux disease in children and adolescents in primary care

By Ruigómez Ana   Wallander Mari-Ann   Lundborg Per   Johansson Saga   Rodriguez Luis A. Garcia  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 2, 2010-02 ,pp. : 139-146

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Pantoprazole versus Ranitidine in the Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease

By  

Digestion, Vol. 70, Iss. 1, 2004-09 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

Empirical Trials in Treatment of Gastroesophageal Reflux Disease

By  

Digestive Diseases, Vol. 18, Iss. 1, 2000-06 ,pp. : 20-26

Karger

Access to resources Recommend Favorite

Endoscopic Therapy for Gastroesophageal Reflux Disease: A Systematic Review

By  

Digestion, Vol. 74, Iss. 1, 2006-11 ,pp. : 1-14

Karger

Access to resources Recommend Favorite